Polymorphisms in ICOS have been associated with pre-disposition to non-small cell lung cancer [62], while over-expression of YWHAZ is known to enhance proliferation and migration of lung cancer cells through induction of epithelial-mesenchymal transitions via beta-catenin signaling [63]. This evidence concerns the gene YWHAZ and lung cancer.